Nephrolithiasis in Cushing's disease: prevalence, etiopathogenesis, and modification after disease cure.
about
Comorbidities in Cushing's diseaseThe relationship between insulin, insulin resistance, parathyroid hormone, cortisol, testosterone, and thyroid function tests in the presence of nephrolithiasis: a comprehensive analysisPhysiological basis for the etiology, diagnosis, and treatment of adrenal disorders: Cushing's syndrome, adrenal insufficiency, and congenital adrenal hyperplasiaThe hypertension of Cushing's syndrome: controversies in the pathophysiology and focus on cardiovascular complications.Cushing's syndrome: epidemiology and developments in disease management.Carney's complex: a successful pregnancy after bilateral adrenalectomy.Kidney Stones as an Underrecognized Clinical Sign in Pediatric Cushing DiseaseQuality of life and other outcomes in children treated for Cushing syndrome.Cushing's syndrome: aftermath of the cure.Chronic Glucocorticoid-Rich Milieu and Liver DysfunctionKidney stones: a fetal origins hypothesisManaging hyperglycemia in patients with Cushing's disease treated with pasireotide: medical expert recommendations.Clinical consequences of Cushing's syndrome.Advances in the epidemiology, pathogenesis, and management of Cushing's syndrome complications.Efficacy of medical treatment in Cushing's disease: a systematic review.Managing Cushing's disease: the state of the art.Clinical and biochemical manifestations of Cushing's.Pathogenesis of calcium oxalate urinary stone disease: species comparison of humans, dogs, and cats.Long-term follow-up of renal function in dogs after treatment for ACTH-dependent hyperadrenocorticism.Trends in pediatric urolithiasis: patient characteristics, associated diagnoses, and financial burden.Management of renal transplant urolithiasis: a multicentre study by the French Urology Association Transplantation Committee.Pharmacophore Modeling and in Silico/in Vitro Screening for Human Cytochrome P450 11B1 and Cytochrome P450 11B2 Inhibitors.Prognostic factors for survival in dogs with pituitary-dependent hypercortisolism treated with trilostane
P2860
Q27010491-F7B4FF78-4955-43FC-9F5D-37259CBD0BCAQ33819928-F47A2F6C-D896-40B4-A4A8-E92CEE34C8A6Q34431162-9E71AF9A-6B13-42DD-ABB0-F4246BF07339Q35126105-58949909-04E1-490E-B1AE-1B6C3E1C1423Q35531889-3EFF535C-70BC-4346-8B94-F41DBC7EF273Q35844008-1FF2A1A2-62D0-4F78-8602-FD57FCD2EF62Q36627004-FE8A0961-EF55-44AB-AF7C-607046B4B2E5Q36981968-02718921-819A-4933-8E2A-45C6E1545977Q37062081-67E26981-BB6F-40E1-91E4-F7DA8CC40C06Q37202033-C09C47CE-25DD-47A2-A5A4-AEB8C7E38088Q37221053-68F07D4D-95BE-4471-BD3E-DB95239F5E6EQ37617500-82B4A9EE-105E-4A55-9013-EFD776A38FCEQ38004913-1F419CE7-880E-4D78-800B-991DCA1E6F16Q38015162-746AF4E1-99F0-47AD-830E-28B1E59AAC95Q38151882-6091C223-6B57-45C5-94F6-0771EC5990C6Q38177740-40B502C8-2FE5-4A2B-94F8-64AC78F5DD71Q38311631-53D2CB21-9B63-42A1-95C3-65810BED57B9Q38737367-949A9B92-9ADE-48E6-86A1-0AD235B3C37DQ39634386-22303E7B-1D80-4D61-AF42-F7EF3DB34454Q41614057-C41AA859-E342-43E5-8273-989EDF0F1A74Q50067131-409302A8-20DA-4822-B229-D26692DDD25BQ50128659-CC71601E-84A0-41CB-A721-7E95F76BEB7BQ56971335-CCA1B718-69DC-44AA-9D32-5630D047C900
P2860
Nephrolithiasis in Cushing's disease: prevalence, etiopathogenesis, and modification after disease cure.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Nephrolithiasis in Cushing's d ...... dification after disease cure.
@en
Nephrolithiasis in Cushing's d ...... dification after disease cure.
@nl
type
label
Nephrolithiasis in Cushing's d ...... dification after disease cure.
@en
Nephrolithiasis in Cushing's d ...... dification after disease cure.
@nl
prefLabel
Nephrolithiasis in Cushing's d ...... dification after disease cure.
@en
Nephrolithiasis in Cushing's d ...... dification after disease cure.
@nl
P50
P356
P1476
Nephrolithiasis in Cushing's d ...... dification after disease cure.
@en
P2093
Daniela Melis
Mariagiovanna Filippella
P304
P356
10.1210/JC.2002-021494
P407
P50
P577
2003-05-01T00:00:00Z